Bristol-Myers Squibb rStock

RBMY

Bristol Myers Squibb engages in the research, development, manufacturing, and commercialized sale of innovative prescription drugs. The R&D focus is centered on severe medical fields such as oncology, hematology, immunology, and cardiovascular diseases. The company operates biological processing plants and small-molecule compound laboratories, advancing the clinical trial procedures for drug candidates. Its approved patented medications are primarily supplied in large volumes to global healthcare service institutions through specialized pharmaceutical distribution channels.